| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | QX3JU54GYQ |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| NEGATIVE ALLOSTERIC MODULATOR | Interleukin-1 beta negative allosteric modulator | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Behcet Syndrome | 3 | D001528 | ClinicalTrials |
| Uveitis | 3 | D014605 | ClinicalTrials |
| Pyoderma | 3 | D011711 | ClinicalTrials |
| Acne Vulgaris | 2 | D000152 | ClinicalTrials |
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Labyrinth Diseases | 2 | D007759 | ClinicalTrials |
| Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
| Osteoarthritis | 2 | D010003 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | 2 | D003924 | ClinicalTrials |
| Scleritis | 1 | D015423 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1129435-60-4 |
| ChEMBL | CHEMBL1743026 |
| FDA SRS | QX3JU54GYQ |
| Guide to Pharmacology | 7394 |
CONTENTS